Combination Therapy With Exenatide Plus Pioglitazone Versus Basal/Bolus Insulin in Patients With Poorly Controlled Type 2 Diabetes on Sulfonylurea Plus Metformin: The Qatar Study

The Qatar Study was designed to examine the efficacy of combination therapy with exenatide plus pioglitazone versus basal/bolus insulin in patients with long-standing poorly controlled type 2 diabetes mellitus (T2DM) on metformin plus a sulfonylurea. The study randomized 231 patients with poorly con...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Diabetes care 2017-03, Vol.40 (3), p.325-331
Hauptverfasser:	Abdul-Ghani, Muhammad, Migahid, Osama, Megahed, Ayman, Adams, John, Triplitt, Curtis, DeFronzo, Ralph A, Zirie, Mahmoud, Jayyousi, Amin
Format:	Artikel
Sprache:	eng
Schlagworte:	Blood Glucose - metabolism Clinical Care/Education/Nutrition/Psychosocial Research Clinical trials Diabetes Diabetes Mellitus, Type 2 - drug therapy Drug therapy Drug Therapy, Combination Exenatide Female Follow-Up Studies Glycated Hemoglobin A - metabolism Hemoglobin Humans Hypoglycemia - blood Hypoglycemia - etiology Hypoglycemic Agents - administration & dosage Hypoglycemic Agents - therapeutic use Insulin Insulin - therapeutic use Male Metformin - therapeutic use Middle Aged Peptides - administration & dosage Peptides - therapeutic use Pioglitazone Qatar Sulfonylurea Compounds - therapeutic use Thiazolidinediones - administration & dosage Thiazolidinediones - therapeutic use Venoms - administration & dosage Venoms - therapeutic use Weight Gain
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!